Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 122 of the 123 references it cites were found in a registry or an index, and 1 are not checked yet; 3 of the 130 sources its claims cite were checked for support.

Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity

Open access

Abstract

Microglia, the resident macrophages of the central nervous system, are recognized for their heterogeneity and integral role in brain function and diseases. In the context of high fat diet (HFD) feeding and obesity, microglia become overactive, acquiring a prevailing lipid associated microglial phenotype (also known as LAM). Yet, how microgliosis is induced and regulated remains unclear. Here we report a key role for the Complement 3a Receptor (C3aR), on HFD-induced hypothalamic gliosis and weight gain in mice. HFD consumption leads to elevated microglial expression of C3aR, which parallels widespread accumulation of reactive microglia, selectively in the hypothalamus. Conditional microglial C3aR deletion protects mice from HFD-induced hypothalamic reactive microgliosis. C3aR deletion or pharmacological antagonism opposes HFD-induced weight gain in male but not female mice. Mechanistically, we demonstrated that C3aR is essential for lipid-induced lipid droplet formation, and acquisition of a LAM molecular signature. In summary, we uncovered a previously unknown role for C3aR in the acquisition of a LAM signature driving diet-induced gliosis, identifying this receptor as a new viable therapeutic candidate for conditions associated with hypothalamic neuroinflammation.

Verified 2026-11-17 · 1 reference not checked yet

Overview

CoChat Summary

TL;DR

In mice, microglial C3aR is selectively expressed by microglia, marks lipid-associated microglia (LAM), and is required for high-fat-diet (HFD)-induced hypothalamic microgliosis/astrogliosis and lipid droplet formation. Conditional microglial C3aR deletion or intranasal C3aR antagonism protects against HFD-induced hypothalamic gliosis and, in male mice on 45% HFD, weight/fat gain.

Key findings

  • C3aR expression was selective to microglia in mouse and human CNS; scRNAseq identified hypothalamic microglial subclusters with foamy/LAM features (FoamDEX > 0.50), with subclusters 4, 7, and 10 showing highest C3ar1 and LAM scores.
  • HFD feeding increased hypothalamic microgliosis and astrogliosis independent of sex and body weight, and increased microglial C3aR; conditional microglial C3aR deletion normalized HFD-induced microgliosis, astrogliosis, amoeboid microglial morphology, CD68, and Trem2+ microglia in both sexes.
  • C3aR deletion protected male mice from 45% HFD-induced obesity but not 60% HFD, and did not protect females; intranasal DArg10_Aib20 in 45% HFD-fed males limited body weight gain and decreased fat mass gain without changing food intake, and protected against hypothalamic microgliosis.
  • In vitro, cholesterol + oleate induced lipid droplets and LAM/inflammatory genes; C3aR antagonism blocked lipid droplet accumulation, and primary microglia from C3aR-deleted mice showed <50% lipid-loaded cells versus >80% in controls.

Methods

  • Mouse genetics and diets: tdTom-C3aR1lox/lox reporter mice and CX3CR1creERT2-mediated conditional microglial C3aR deletion; tamoxifen 100 mg/kg for 5 days; standard diet, 45% HFD, or 60% HFD for up to 12 weeks; n = 10–12/group/sex for SD/45% HFD and n = 5/group/sex for 60% HFD; body weight, EchoMRI, CLAMS indirect calorimetry, and glucose tolerance tests.
  • Pharmacological and imaging experiments: intranasal DArg10_Aib20 (8.33 μg/μl; 12 μl/day; 100 μg daily) or saline for 12 weeks in 45% HFD-fed male mice; Cy5-TLQP-21 in vivo imaging via IVIS.
  • In vitro and transcriptomic analysis: BV2 or primary microglia lipid-loaded with 20 μg/ml cholesterol + 400 μM oleic acid; BODIPY staining; antagonists SB290157 (20 μM), JR14a (1 μM), or DArg10_Aib20 (20 μM); public scRNAseq datasets analyzed with Seurat/Harmony, FoamDEX, and LAM scores.

Limitations

  • Stated: the mechanism of sex-dependent vulnerability needs further study; further sequencing is needed to determine how hypothalamic microglial subclusters shift in diet-induced obesity; the functional implication of a slight reduction in cumulative energy expenditure in male C3aR1lox/lox-CreER+ mice on 45% HFD is currently unclear.
  • Stated/evident: CX3CR1creERT2 can target some peripheral macrophages; the authors found transient C3aR depletion in the small intestine at 2 weeks post-tamoxifen that was later replenished, and state this may have limited metabolic effect.
  • Evident: the protective metabolic effect was limited to male mice on 45% HFD, not 60% HFD or females, so generalizability across sexes and diet fat levels is constrained.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.64898/2026.04.18.719397

Cites

122 of 123 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. scRNAseq reveals hypothalamic microglial subclusters which are more LAM-like, of which includes C3aR, under physiological, non-obesity conditions. A) UMAP projection of murine hypothalamus combined scRNAseq datasets showing identified microglial cell subclusters. B) Average expression of Aif1 (Iba1), C3aR1, and other LAM genes of interest across the 13 microglial subclusters. C) UMAP projection showing FoamDEX score (for identification of foamy macrophages) as determined using MACanalyzeR scRNAseq analysis tools across the various microglial subclusters (FoamDEX score > 0.5 is considered a foamy macrophage). D) Heatmap showing average expression of 20 genes across the hypothalamic microglial subclusters that contribute towards the FoamDEX score, with C3aR1 and Aif1 included. E) UMAP projection showing LAM score, a similar but separate index that mirrors the FoamDEX scores across the subclusters. F) Ridgeline plot showing the LAM score across the 13 hypothalamic microglial subclusters, with subclusters 4, 7, and 10 being the most LAM-like. G) Heatmap showing average expression of 14 genes across the hypothalamic microglial subclusters that contribute towards the LAM score, with C3aR1 included.
Figure 1. scRNAseq reveals hypothalamic microglial subclusters which are more LAM-like, of which includes C3aR, under physiological, non-obesity conditions. A) UMAP projection of murine hypothalamus combined scRNAseq datasets showing identified microglial cell subclusters. B) Average expression of Aif1 (Iba1), C3aR1, and other LAM genes of interest across the 13 microglial subclusters. C) UMAP projection showing FoamDEX score (for identification of foamy macrophages) as determined using MACanalyzeR scRNAseq analysis tools across the various microglial subclusters (FoamDEX score > 0.5 is considered a foamy macrophage). D) Heatmap showing average expression of 20 genes across the hypothalamic microglial subclusters that contribute towards the FoamDEX score, with C3aR1 and Aif1 included. E) UMAP projection showing LAM score, a similar but separate index that mirrors the FoamDEX scores across the subclusters. F) Ridgeline plot showing the LAM score across the 13 hypothalamic microglial subclusters, with subclusters 4, 7, and 10 being the most LAM-like. G) Heatmap showing average expression of 14 genes across the hypothalamic microglial subclusters that contribute towards the LAM score, with C3aR1 included.CC BY-NC-ND · PubMed Central
Figure 2. Characterization of diet-induced microgliosis and tdTom-C3aR expression under conditions of diet-induced obesity. 4-month-old male tdTom-C3aR1lox/lox animals placed either on 60% HFD for 12 weeks showing increased body weight gain (A; p=0.0016) and fat mass contribution to overall body weight (B; %FM/BW; p=0.0008) due to HFD and compared to animals on SD. Unpaired two-sided t-tests; N=4/group. Quantification (C) and representative 20x stitched IF images (D) showing increased global microglial density (total Iba1+ counts across 4–6 coronal sections/animal divide by total tissue area) spanning the full thickness of the hypothalamus as a consequence of 12 weeks of HFD consumption (p=0.0051). Unpaired two-sided t-tests. Scale bars represent 100μm. Representative 10x IF images (E) and quantification (F) showing a lack of a HFD effect on microglial density in the hippocampus and somatosensory cortex. Scale bars represent 100μm. Representative 10x IF images (G) and quantification (H) showing diet-induced hypothalamic microglial density (Bregma −0.94mm, p=0.0039) paralleled by increased tdTom-C3aR expression (p=0.0071). Scale bars represent 30μm. Unpaired two-sided t-tests. ** indicates p<0.01, *** indicates p<0.001. Error bars represent standard error of the mean (SEM).
Figure 2. Characterization of diet-induced microgliosis and tdTom-C3aR expression under conditions of diet-induced obesity. 4-month-old male tdTom-C3aR1lox/lox animals placed either on 60% HFD for 12 weeks showing increased body weight gain (A; p=0.0016) and fat mass contribution to overall body weight (B; %FM/BW; p=0.0008) due to HFD and compared to animals on SD. Unpaired two-sided t-tests; N=4/group. Quantification (C) and representative 20x stitched IF images (D) showing increased global microglial density (total Iba1+ counts across 4–6 coronal sections/animal divide by total tissue area) spanning the full thickness of the hypothalamus as a consequence of 12 weeks of HFD consumption (p=0.0051). Unpaired two-sided t-tests. Scale bars represent 100μm. Representative 10x IF images (E) and quantification (F) showing a lack of a HFD effect on microglial density in the hippocampus and somatosensory cortex. Scale bars represent 100μm. Representative 10x IF images (G) and quantification (H) showing diet-induced hypothalamic microglial density (Bregma −0.94mm, p=0.0039) paralleled by increased tdTom-C3aR expression (p=0.0071). Scale bars represent 30μm. Unpaired two-sided t-tests. ** indicates p<0.01, *** indicates p<0.001. Error bars represent standard error of the mean (SEM).CC BY-NC-ND · PubMed Central
Figure 3. Conditional depletion of microglial C3aR protects against diet-induced obesity and hypothalamic microgliosis. A) Experimental timeline for in vivo studies. Change in body weight from baseline comparisons within male (B) or female (C) C3aR1lox/lox-CreER- or C3aR1lox/lox-CreER+ mice fed either SD, 45% HFD, or 60% HFD for 12 weeks. Male Cre+ animals on 45% HFD were protected against diet-induced weight gain meanwhile female mice regardless of genotype were resistant to 45% HFD-induced weight gain. Males 2-way ANOVA. Diet (main) effect: F(2,50)=18.58, p<0.0001; Genotype effect: F(1,49)=2.415, p=0.1265; Interaction: F(2,50)=1.422, p=0.2507). Females 2-way ANOVA. Diet (main) effect: F(2,47)=26.65, p<0.0001; Genotype effect: F(1,47)=0.02555, p=0.8737; Interaction: F(2,47)=0.3026, p=0.7403). Tukey’s post hoc]. Animals: SD & 45%HFD, N=10–12/genotype/sex; 60% N=5/genotype/sex. Representative 10x IF images (D) and quantification (E) showing HFD-induced hypothalamic microgliosis that was reduced in animals lacking microglial C3aR. Diet-induced hypothalamic microgliosis was protected when microglial C3aR was ablated in both male and female animals, and regardless of which HFD diet they were on. 2-way ANOVA. Diet (main) effect: F(2,45)=23.12, p<0.0001; Genotype effect: F(1,45)=23.41, p<0.0001; Interaction: F(2,45)=7.515, p=0.0015). F) Flow cytometry showing elevated whole brain microglial counts after 12 weeks of 45% HFD that was mitigated in animals with ablated microglial C3aR, consistent with the histology performed on replicate animals in C/D. Sexes were pooled although there appears to be clustering based on sex in HFD-fed CreER+ animals (Fig.S4C). Pooled 2-way ANOVA. Diet (main) effect: F(1,40)=52.62, p<0.0001; Genotype effect: F(1,40)=9.353, p=0.0040; Interaction: F(1,40)=5.290, p=0.0267). Representative IF images (G) and quantification (H) showing HFD-induced hypothalamic astrogliosis that was also reduced in animals lacking microglial C3aR, despite these astrocytes not expressing C3aR. Quantification shows an increase in percent area occupied by GFAP+ pixels in 10x magnification images (20x magnification images shown for representative images, G). Scale bars represent 30μm. 2-way ANOVA. Diet (main) effect: F(2,43)=15.79, p<0.0001; Genotype effect: F(1,43)=23.34, p<0.0001; Interaction: F(2,42)=13.16, p<0.0001). Error bars represent standard error of the mean (SEM).
Figure 3. Conditional depletion of microglial C3aR protects against diet-induced obesity and hypothalamic microgliosis. A) Experimental timeline for in vivo studies. Change in body weight from baseline comparisons within male (B) or female (C) C3aR1lox/lox-CreER- or C3aR1lox/lox-CreER+ mice fed either SD, 45% HFD, or 60% HFD for 12 weeks. Male Cre+ animals on 45% HFD were protected against diet-induced weight gain meanwhile female mice regardless of genotype were resistant to 45% HFD-induced weight gain. Males 2-way ANOVA. Diet (main) effect: F(2,50)=18.58, p<0.0001; Genotype effect: F(1,49)=2.415, p=0.1265; Interaction: F(2,50)=1.422, p=0.2507). Females 2-way ANOVA. Diet (main) effect: F(2,47)=26.65, p<0.0001; Genotype effect: F(1,47)=0.02555, p=0.8737; Interaction: F(2,47)=0.3026, p=0.7403). Tukey’s post hoc]. Animals: SD & 45%HFD, N=10–12/genotype/sex; 60% N=5/genotype/sex. Representative 10x IF images (D) and quantification (E) showing HFD-induced hypothalamic microgliosis that was reduced in animals lacking microglial C3aR. Diet-induced hypothalamic microgliosis was protected when microglial C3aR was ablated in both male and female animals, and regardless of which HFD diet they were on. 2-way ANOVA. Diet (main) effect: F(2,45)=23.12, p<0.0001; Genotype effect: F(1,45)=23.41, p<0.0001; Interaction: F(2,45)=7.515, p=0.0015). F) Flow cytometry showing elevated whole brain microglial counts after 12 weeks of 45% HFD that was mitigated in animals with ablated microglial C3aR, consistent with the histology performed on replicate animals in C/D. Sexes were pooled although there appears to be clustering based on sex in HFD-fed CreER+ animals (Fig.S4C). Pooled 2-way ANOVA. Diet (main) effect: F(1,40)=52.62, p<0.0001; Genotype effect: F(1,40)=9.353, p=0.0040; Interaction: F(1,40)=5.290, p=0.0267). Representative IF images (G) and quantification (H) showing HFD-induced hypothalamic astrogliosis that was also reduced in animals lacking microglial C3aR, despite these astrocytes not expressing C3aR. Quantification shows an increase in percent area occupied by GFAP+ pixels in 10x magnification images (20x magnification images shown for representative images, G). Scale bars represent 30μm. 2-way ANOVA. Diet (main) effect: F(2,43)=15.79, p<0.0001; Genotype effect: F(1,43)=23.34, p<0.0001; Interaction: F(2,42)=13.16, p<0.0001). Error bars represent standard error of the mean (SEM).CC BY-NC-ND · PubMed Central
Figure 4. Conditional depletion of microglial C3aR protects against diet-induced changes in microglial activation. A) Representative IF images at 60x conveying differences in microglial morphological complexity across diets, notably retracted processes and simplification of arborizations due to 45% HFD that is fully restored in the absence of microglial C3aR. Scale bars represent 30μm. B) Sholl analysis displaying the number of intersections at every 1μm radii concentric circle radiating from cell soma, up to 45μm radii circles. C) The total area under the curve was calculated per group with male and females pooled due lack of sex differences (sex factor, p=0.1550). Each animal per group is represented by 3 random, averaged fields of view as this is a nested analysis. 1-way ANOVA followed by Tukey multiple comparisons test. *** indicates p<0.001, **** indicates p<0.0001. D) Representative 10x IF images showing hypothalamic CD68 expression depending on diet conditions that colocalizes with microglia. There is an observable increase in Iba1 cells colocalizing with CD68 due to diet exposure that is mitigated by deletion of C3aR1, quantification normalized to tissue area shown in E. 1-way ANOVA followed by Tukey multiple comparisons test. ** indicates p<0.01, *** indicates p<0.001. Scale bars represent 50μm. Error bars represent standard error of the mean (SEM).
Figure 4. Conditional depletion of microglial C3aR protects against diet-induced changes in microglial activation. A) Representative IF images at 60x conveying differences in microglial morphological complexity across diets, notably retracted processes and simplification of arborizations due to 45% HFD that is fully restored in the absence of microglial C3aR. Scale bars represent 30μm. B) Sholl analysis displaying the number of intersections at every 1μm radii concentric circle radiating from cell soma, up to 45μm radii circles. C) The total area under the curve was calculated per group with male and females pooled due lack of sex differences (sex factor, p=0.1550). Each animal per group is represented by 3 random, averaged fields of view as this is a nested analysis. 1-way ANOVA followed by Tukey multiple comparisons test. *** indicates p<0.001, **** indicates p<0.0001. D) Representative 10x IF images showing hypothalamic CD68 expression depending on diet conditions that colocalizes with microglia. There is an observable increase in Iba1 cells colocalizing with CD68 due to diet exposure that is mitigated by deletion of C3aR1, quantification normalized to tissue area shown in E. 1-way ANOVA followed by Tukey multiple comparisons test. ** indicates p<0.01, *** indicates p<0.001. Scale bars represent 50μm. Error bars represent standard error of the mean (SEM).CC BY-NC-ND · PubMed Central
Figure 5. Pharmacological antagonism or deletion of C3aR protects against lipid-induced changes, in vivo and in vitro. A) Change in body weight over time of male mice on 45% HFD receiving daily intranasal administration of saline or DArg10_Aib20 (100μg/day in 12μl). Two-way ANOVA with repeated measures followed by Šídák’s multiple comparisons test (treatment p=0.0392); N=9/group. Final change in body weight (B; p=0.0029), fat mass (C; p=0.0458), and lean mass (D; p=0.1699) relative to baseline of HFD-fed male animals receiving intranasal saline or DArg10_Aib20; Unpaired, one-sided t-tests. E) Cumulative caloric intake over time of HFD-fed male mice receiving intranasal saline or DArg10_Aib20. Two-way ANOVA with repeated measures followed by Šídák’s multiple comparisons test (treatment p=0.3235). Representative IF images (F) and quantification (G) showing HFD-induced hypothalamic microgliosis that was reduced in DArg10_Aib20 treated mice (p=0.0323). 1-way ANOVA (compared to SD fed, control animals) followed by Tukey multiple comparisons test. Scale bars represent 100μm. * indicates p<0.05, ** indicates p<0.01. Error bars represent standard error of the mean (SEM).
Figure 5. Pharmacological antagonism or deletion of C3aR protects against lipid-induced changes, in vivo and in vitro. A) Change in body weight over time of male mice on 45% HFD receiving daily intranasal administration of saline or DArg10_Aib20 (100μg/day in 12μl). Two-way ANOVA with repeated measures followed by Šídák’s multiple comparisons test (treatment p=0.0392); N=9/group. Final change in body weight (B; p=0.0029), fat mass (C; p=0.0458), and lean mass (D; p=0.1699) relative to baseline of HFD-fed male animals receiving intranasal saline or DArg10_Aib20; Unpaired, one-sided t-tests. E) Cumulative caloric intake over time of HFD-fed male mice receiving intranasal saline or DArg10_Aib20. Two-way ANOVA with repeated measures followed by Šídák’s multiple comparisons test (treatment p=0.3235). Representative IF images (F) and quantification (G) showing HFD-induced hypothalamic microgliosis that was reduced in DArg10_Aib20 treated mice (p=0.0323). 1-way ANOVA (compared to SD fed, control animals) followed by Tukey multiple comparisons test. Scale bars represent 100μm. * indicates p<0.05, ** indicates p<0.01. Error bars represent standard error of the mean (SEM).CC BY-NC-ND · PubMed Central
Figure 6. C3aR is important for adoption of LAM phenotype and diet-induced lipid droplet accumulation. Representative images (A) and quantification (B) showing a diet-induced increase in hypothalamic microglia positive for Trem2 that is protected against in absence of microglial C3aR. 1-way ANOVA followed by Tukey multiple comparisons test. ** indicates p<0.01. C) Representative 60x fluorescent images showing lipid droplets in DAPI/BODIPY stained BV2 cells treated with Chol. + OA [C+O] for 18 hours with one of various C3aR antagonists; SB290157, JR14a, or DArg10_Aib20. Scale bars represent 20μm. BODIPY fluorescent intensity quantification normalized to numbers of cells within each field of view for the various groups (D). 1-way ANOVA followed by Tukey multiple comparisons test. *** indicates p<0.001, **** indicates p<0.0001. E) Representative flow cytometry plot showing identification of tdTom presence/absence in primary microglia isolated from CreER- or CreER+ animals via MACS. F) Representative 60x magnification images showing primary cells immunostained with Iba1 and then with DAPI and BODIPY. G) Quantification showing a reduction in Iba1+ cells that are also BODIPY+ in primary microglia from CreER+ animals (Chi-square statistic with Yates correction = 16.4987; p-value is 0.000049). Error bars represent standard error of the mean (SEM).
Figure 6. C3aR is important for adoption of LAM phenotype and diet-induced lipid droplet accumulation. Representative images (A) and quantification (B) showing a diet-induced increase in hypothalamic microglia positive for Trem2 that is protected against in absence of microglial C3aR. 1-way ANOVA followed by Tukey multiple comparisons test. ** indicates p<0.01. C) Representative 60x fluorescent images showing lipid droplets in DAPI/BODIPY stained BV2 cells treated with Chol. + OA [C+O] for 18 hours with one of various C3aR antagonists; SB290157, JR14a, or DArg10_Aib20. Scale bars represent 20μm. BODIPY fluorescent intensity quantification normalized to numbers of cells within each field of view for the various groups (D). 1-way ANOVA followed by Tukey multiple comparisons test. *** indicates p<0.001, **** indicates p<0.0001. E) Representative flow cytometry plot showing identification of tdTom presence/absence in primary microglia isolated from CreER- or CreER+ animals via MACS. F) Representative 60x magnification images showing primary cells immunostained with Iba1 and then with DAPI and BODIPY. G) Quantification showing a reduction in Iba1+ cells that are also BODIPY+ in primary microglia from CreER+ animals (Chi-square statistic with Yates correction = 16.4987; p-value is 0.000049). Error bars represent standard error of the mean (SEM).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

1 Valid · 1 Not valid · 34 Not checked · 83 Own results and interpretations

41 more claims

Create a free account to see all 119 claims and to verify the 127 references still open.

See all claims — free account
  • It may state two separate claims as one. 59
  • Probably not a substantial claim. 29

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 120 references

Research works printed but not linked: 6

  1. 10.1016/j.tins.2017.02.005/attachment/54e28e50-9278-4d91-b850-bcb32105363e/mmc1.docx · doi:10.1016/j.tins.2017.02.005/attachment/54e28e50-9278-4d91-b850-bcb32105363e/mmc1.docx
  2. 10.3389/fneur.2024.1396520/bibtex · doi:10.3389/fneur.2024.1396520/bibtex
  3. 10.1101/2024.09.24.614807 · DOI · Paper page
  4. 10.1126/scitranslmed.aaf6295/suppl_file/aaf6295_sm.pdf · doi:10.1126/scitranslmed.aaf6295/suppl_file/aaf6295_sm.pdf
  5. 10.3389/fnins.2021.734158/full · doi:10.3389/fnins.2021.734158/full
  6. 10.1186/s12974-016-0666-8/figures/5 · doi:10.1186/s12974-016-0666-8/figures/5

Metadata

Authors
Pallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., Wang, H., Veglia, G., Köhl, J., Bose, M., Ehrlich, M. E., Salton, S. R. J., Araque, A., Barbato, D. L., Revelo, X. S., Ruan, H.-B., Williams, J. W., & Bartolomucci, A.
Affiliations
  • University of Minnesota (US)
  • University of Rome Tor Vergata (IT)
  • University of Lübeck (DE)
  • Icahn School of Medicine at Mount Sinai (US)
  • Department of Biology, University of Rome Tor Vergata, Rome, Italy
Corresponding author
Bartolomucci, Alessandro
Venue
Journal of Neuroinflammation
Publisher
openRxiv
Published
2026-04-22
ISSN
1742-2094 (ISSN-L)
OpenAlex
W7215059476
Cited by
1
References
120
Citations by year
2026: 1
FWCI
2.06
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (submittedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (R01AI165553)
  • Institute for Diabetes Obesity and Metabolism University of Minnesota (2022 Pilot and Feasibility Program)
  • Minnesota Partnership for Biotechnology and Medical Genomics (24.01)
  • American Heart Association (25PRE1361476)
  • Cure Alzheimer’s Fund
  • MN Dept. of Education Award (214654)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
C3aR, microglial activation, hypothalamus, high-fat diet, obesity, neuroinflammation, lipid droplet formation, transcriptional remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity. https://app.cochat.ai/papers/10.64898/2026.04.18.719397
The paper
Pallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., Wang, H., Veglia, G., Köhl, J., Bose, M., Ehrlich, M. E., Salton, S. R. J., Araque, A., Barbato, D. L., Revelo, X. S., . . . Bartolomucci, A. (2026). Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity. Journal of Neuroinflammation. https://doi.org/10.64898/2026.04.18.719397

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.